Related Experiment Video
Updated: Feb 18, 2026

04:45
Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
Published on: June 2, 2022
2.9K
Inflammatory processes during acute respiratory distress syndrome: a complex system
Lucy K Reiss1, Andreas Schuppert2, Stefan Uhlig1
1Institute of Pharmacology and Toxicology, Medical Faculty, RWTH Aachen University.
Current Opinion in Critical Care
|November 28, 2017
Summary
Inflammation in Acute Respiratory Distress Syndrome (ARDS) is complex, not a single process. A systems approach is needed for effective ARDS therapies, considering intricate inflammatory circuits and regulatory networks.
Area of Science:
- Pulmonary Medicine
- Immunology
- Systems Biology
Background:
- Acute Respiratory Distress Syndrome (ARDS) involves severe pulmonary inflammation.
- Current inflammation-targeted therapies for ARDS have shown limited success.
- The complexity of inflammatory processes in ARDS may be underestimated.
Purpose of the Study:
- To summarize recent findings on the complex interrelations within inflammatory circuits in ARDS.
- To highlight the need for a systems-level understanding of inflammation in ARDS.
- To propose a new therapeutic strategy based on systems biology.
Main Methods:
- Review of gene expression analyses from ARDS, sepsis, and trauma models/patients.
- Analysis of regulatory circuits including inflammasome, autophagy, and apoptosis.
- Integration of model-driven simulations, data-driven modeling, and experimental studies.
Main Results:
- Gene expression data reveal significant overlaps across ARDS, sepsis, and trauma, underscoring inflammation's complexity.
- Inflammation in ARDS is proposed as a scale-free network system with adaptable hubs (e.g., NFκB).
- Mild and life-threatening ARDS inflammation represent distinct, non-linear processes.
Conclusions:
- A systems approach to inflammation is crucial for developing effective ARDS therapies.
- Understanding complex inflammatory circuits is key to improving patient outcomes.
- Therapeutic interventions should consider the dynamic and adaptive nature of ARDS inflammation.
Related Concept Videos
Acute Respiratory Failure-V
525
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
525
Acute Respiratory Failure-IV
599
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
599
Acute Respiratory Failure-II
1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-I
1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-III
966
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
966
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.8K

